Chromocell Therapeutics Corp (CHRO)
2.32
+0.49
(+26.78%)
USD |
NYAM |
May 13, 13:47
Chromocell Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
iBio Inc | -- |
Lixte Biotechnology Holdings Inc | -- |
PDS Biotechnology Corp | -- |
Syros Pharmaceuticals Inc | 2.474 |
Nutriband Inc | 0.0322 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 0.0228M |
Total Liabilities (Quarterly) | 5.927M |
Shareholders Equity (Quarterly) | -5.905M |